TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT05084053 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-05-29 3. primary completion date: 2024-03-05 → 2025-10-28
Clinical trial NCT05084053 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-05-29 3. primary completion date: 2024-03-05 → 2025-10-28
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical